Exploring the mechanism of inhibition of human telomerase by cysteine-reactive compounds

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Telomerase is an almost universal cancer target that consists minimally of a core protein human telomerase reverse transcriptase (hTERT) and a RNA component human telomerase RNA (hTR). Some inhibitors of this enzyme are thought to function by the covalent binding to one or several cysteine residues; however, this inhibition mechanism has never been investigated because of the difficulty in producing telomerase. In this study, we use a recent method to produce recombinant hTERT to analyze the effect of cysteine-reactive inhibitors on telomerase. Using mass spectrometry and mutagenesis analysis, we identify several targeted residues in separated domains of the hTERT protein and show that cysteine-reactive reagents abolish the interaction with the CR4/5 region of hTR.

Author supplied keywords

Cite

CITATION STYLE

APA

Kellermann, G., Dingli, F., Masson, V., Dauzonne, D., Ségal-Bendirdjian, E., Teulade-Fichou, M. P., … Bombard, S. (2017). Exploring the mechanism of inhibition of human telomerase by cysteine-reactive compounds. FEBS Letters, 591(6), 863–874. https://doi.org/10.1002/1873-3468.12589

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free